Hepatitis D medical therapy: Difference between revisions
Varun Kumar (talk | contribs) (Created page with "{{Hepatitis D}} {{CMG}} ==Medical Therapy== Many of the medicines used to treat hepatitis B are not helpful for treating hepatitis D. Persons with long-term HDV infection ...") |
Varun Kumar (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{Hepatitis D}} | {{Hepatitis D}} | ||
{{CMG}} | {{CMG}}; {{AOEIC}} {{VK}} | ||
==Medical Therapy== | ==Medical Therapy== | ||
There is no specific available treatment. For persons with severe [[hepatitis]], only supportive care is given. The treatment of chronic active [[hepatitis B]] and coexistent hepatitis D infection with [[alpha interferon]] would be done only after consultation and referral to a gastroenterologist. Monitoring HDV RNA and serological levels of [[HBsAg]] may help in management of these patients. | |||
Follow-up for 6months may be recommended in these patients to evaluate for the development of chronic HBV and HDV infection. | |||
==References== | ==References== | ||
| Line 8: | Line 11: | ||
[[Category:Hepatitis|D]] | [[Category:Hepatitis|D]] | ||
[[Category:Viruses]] | [[Category:Viruses]] | ||
[[Category:Disease]] | |||
[[Category:Infectious disease]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 18:40, 16 March 2012
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D medical therapy On the Web |
|
American Roentgen Ray Society Images of Hepatitis D medical therapy |
|
Risk calculators and risk factors for Hepatitis D medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]
Medical Therapy
There is no specific available treatment. For persons with severe hepatitis, only supportive care is given. The treatment of chronic active hepatitis B and coexistent hepatitis D infection with alpha interferon would be done only after consultation and referral to a gastroenterologist. Monitoring HDV RNA and serological levels of HBsAg may help in management of these patients.
Follow-up for 6months may be recommended in these patients to evaluate for the development of chronic HBV and HDV infection.